Pharmacies dispensing opioid substitution therapy also play a role in hepatitis C virus elimination

QR Code

Pharmacies dispensing opioid substitution therapy also play a role in hepatitis C virus elimination

Bibliographic Details
Main Authors:	Gunn, J., Higgs, Peter
Format:	Journal Article
Published:	2018
Online Access:	http://hdl.handle.net/20.500.11937/69137

Similar Items

Pharmacy-led hepatitis C treatment pathways to help ensure elimination
by: Gunn, J., et al.
Published: (2019)

The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs
by: Aitken, C., et al.
Published: (2017)

The impact of dispensing fees on compliance with opioid substitution therapy: a mixed methods study
by: Shepherd, A., et al.
Published: (2014)

The long winding road of opioid substitution therapy implementation in South-East Asia: challenges to scale up
by: Reid, G., et al.
Published: (2014)

A response to: Self-reported and actual hepatitis C virus status
by: O'Keefe, D., et al.
Published: (2014)

Reliability modelling of dispensing processes in community pharmacy
by: Naybour, M., et al.
Published: (2018)

Preventing hepatitis C virus transmission among young people in the justice system
by: Lenton, E., et al.
Published: (2013)

Prescription opioid analgesics for pain management in Australia: 20 years of dispensing
by: Islam, M., et al.
Published: (2016)

Applying reliability engineering techniques to the process of community pharmacy dispensing
by: Naybour, Matthew
Published: (2020)

Safe dispensing practice: development and evaluation of a blended learning tool to enhance dispensing in pharmacy practice education
by: Hope, D., et al.
Published: (2011)

Understanding HIV and hepatitis C virus risk among incarcerated young men with histories of injecting drug use
by: Walker, S., et al.
Published: (2019)

Broad neutralization of hepatitis C virus-resistant variants by Civacir hepatitis C immunoglobulin
by: Tawar, Rajiv G., et al.
Published: (2016)

Stem cell therapy in dengue virus-infected BALB/C Mice improves hepatic injury
by: Sakinah, S., et al.
Published: (2021)

Rapid testing for hepatitis C does not infer current infection
by: Nguyen, V., et al.
Published: (2017)

Sequence and genome analysis of hepatitis C virus
by: Hamzah, Hairul Aini
Published: (2017)

The impact of opioid substitution therapy on mortality post-release from prison: Retrospective data linkage study
by: Degenhardt, L., et al.
Published: (2014)

Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs
by: O’Keefe, D., et al.
Published: (2013)

Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: Comparison of Indigenous and non-Indigenous Australians
by: Gisev, N., et al.
Published: (2014)

Differential patterns of adherence to opioid therapy in opioid naïve and opioid existing patients with different age groups
by: Zin, Che Suraya, et al.
Published: (2019)

Biodynamics of Hepatitis C virus in haemodialysis patients in Pahang
by: Abdul Majid, Mohammed Saad, et al.
Published: (2012)

Hepatitis C virus (HCV) diagnosis via microfluidics
by: Narayanamurthy, Vigneswaran, et al.
Published: (2021)

Hepatitis C virus diagnosis using microfluidics technique
by: Fahmi, Samsuri, et al.
Published: (2021)

High prevalence of smoking and respiratory symptoms of patients on opioid substitution treatment
by: Nelson, Peter, et al.
Published: (2013)

What proportion of prescription items dispensed in community pharmacies are eligible for the New Medicine Service?
by: Wells, Katharine M., et al.
Published: (2014)

Effectiveness of a protocolized dispensing service in community pharmacy for improving patient medication knowledge
by: Abaurre-Labrador, R., et al.
Published: (2016)

Utilising community pharmacy dispensing records to disclose errors in hospital admission drug charts
by: Tompson, A., et al.
Published: (2012)

Evaluation of a community pharmacy dispensing process using a Coloured Petri Net
by: Naybour, M., et al.
Published: (2018)

Dispensing Errors Of Unit Dose Drug Distribution System At Central Pharmacy Of Penang Hospital
by: Elrhman, Gamila Badr A.
Published: (2010)

Detection of Hepatitis C Virus Co-Infection in Hepatitis B Virus positive patient / Muhamad Azhar Muhamad Yusof
by: Muhamad Yusof, Muhamad Azhar
Published: (2015)

Self-medication practice in Yemen and the role of community pharmacy dispensers, pharmacy education, and health authorities / Sami Mohammed Hamood Albawani
by: Hamood Albawani, Sami Mohammed
Published: (2018)

Hepatitis C virus seroprevalence and associated risk factors among male drug injectors in Kermanshah, Iran
by: Sharhani, A., et al.
Published: (2017)

Mixed-genotypes infections with hepatitis C virus in hemodialysis subjects.
by: Hamzah, Hairul Aini, et al.
Published: (2012)

Hepatitis E c=virus: an emerging enigmatic and underestimated pathogen
by: Raji, Yakubu Egigogo, et al.
Published: (2021)

Exploring safety systems for dispensing in community pharmacies: focusing on how staff relate to organizational components
by: Harvey, Jasmine, et al.
Published: (2015)

Prevention, disease control can help eliminate viral hepatitis
by: New Straits Times
Published: (2020)

Determining the impact of opioid substitution therapy upon mortality and recidivism among prisoners: A 22 year data linkage study
by: Gisev, N., et al.
Published: (2015)

Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol
by: Nielsen, S., et al.
Published: (2018)

Decreased IFNI? production correlates with diminished production of cytokines by dendritic cells in patients infected with hepatitis C virus and receiving therapy
by: Hammond, T., et al.
Published: (2011)

Decreased IP-10 and elevated TGFß1 levels are associated with viral clearance following therapy in patients with hepatitis C virus
by: Lee, S., et al.
Published: (2010)

Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus recover genotype cross-reactive neutralising antibodies to HCV during antiretroviral therapy
by: Lee, S., et al.
Published: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nf5983jp7d715kg105eun438bf